INTRODUCTION
IgA is present in normal human serum at about one-fifth of the concentration of IgG. However, it is catabolized around five times faster than IgG and therefore the rates of synthesis of the two immunoglobulins must be similar [1] . IgA is the-most abundant immunoglobulin in secretions. Secretory IgA (sIgh) is the product of local synthesis at the mucosal surfaces which are the main source of antigenic material for the body. In mucosal tissue, IgA synthesis far exceeds that of other classes. As a result, in man, more IgA is produced than all other immunoglobulin classes combined. In contrast to other immunoglobulins, human IgA displays a unique heterogeneity in its molecular forms, each with a characteristic distribution in various body fluids [2] . Human IgA occurs in two isotypic forms, IgAl and IgA2, with IgA2 existing as two allotypic variants IgA2m(l) and IgA2m (2) . Each of these forms is found in various degrees of aggregation.
Although the importance of IgA in mucosal secretions is well established, it is now clear that in humans much of the IgA is secreted directly into the blood and never reaches the mucosal surfaces [3] . Serum IgA is predominantly monomeric IgAl which is produced in the bone marrow, while in external secretions most of the locally produced IgA is polymeric with a relative increase in the proportion of IgA2 [4, 5] . The lymphocytes which produce monomeric or polymeric IgA, IgAl or IgA2 are characteristically distributed in various lymphoid and nonlymphoid tissues. The differential interaction of monomeric and polymeric IgA molecules with various cells leads to their selective distribution in body fluids and possibly to differences in their effector functions. Secretory and serum IgA are therefore molecules with different biochemical and immunochemical properties produced by cells with different organ distributions. The high concentration ot monomeric serum IgA is unique to man, most laboratory animals having much lower concentrations of serum IgA which is predominantly polymeric [6] . Various methods of immunization can induce an immune response of serum and/or secretory IgA [7, 8] . Although most of the serum IgA is monomeric, recent studies indicate that specific serum IgA antibodies induced by either mucosal or systemic immunizations with microbial or dietary antigens can appear first in the dimeric form [9, 10] . The synthesis of IgA and its control has been the main subject of other reviews [5, 11, 12] and therefore it will not be covered here in detail. This review will concentrate on the structure of the different species of IgA and on biochemistry of their interactions with other proteins, both humoral and cellular, which are pertinent to the effector functions of the molecule.
In spite of its abundance, relatively little is known about the functions of IgA. The biochemical characterization of the different forms of IgA, the improvement in methods of purification and the availability of monoclonal antibodies against each isotype has allowed a reappraisal of the immunology of these proteins. Recent research suggests a more active role in immunity than previously considered. Serum IgA had been shown to prevent activation of the complement system and to inhibit phagocytosis, chemotaxis and antibody-dependent cellular cytotoxicity [13] [14] [15] . These results suggested that the predominant role of serum IgA was the removal of antigenic substances without the generation of an inflammatory response. However, more recent work has shown that IgA can activate complement and will efficiently trigger cell-mediated events [16] [17] [18] .
The idea of a passive role for serum IgA in immunity was reinforced by the observation that IgA deficiency is relatively common and is not usually associated with markedly impaired resistance to infection [19] . There is however, compelling evidence for an important role for secretory IgA in immunity [20] [21] [22] . Furthermore, serum IgA levels are frequently raised in rheumatic diseases and in other autoimmune diseases as well as in liver disease and persistent infections such as bacterial endocarditis and AIDS [23] [24] [25] . Elevated IgA levels are associated with rises in serum polymeric IgA, circulating IgA-containing immune complexes and IgA rheumatoid factor. Immune complexes containing IgA have been suggested to be pathogenic in these and other diseases such as IgA nephropathy, a common cause of kidney failure [26, 27] .
THE STRUCTURE OF IgA
Monomeric IgA comprises two heavy and two light chains, the light chains being the same as those found in other immunoglobulins. Electron microscopy suggests the common Y-shaped structure [28] . The The amino acid sequences of IgAs from man, mouse and rabbit have been determined or deduced [29] [30] [31] [32] [33] [34] . They show around 50 % homology. Although all of the intradomain disulphide bonds appear to be conserved, some cysteines, probably involved in interchain disulphide bonds, are not. The C-terminus of the a chain, like that of the ,u chain, extends 18 amino acids relative to that of other heavy chains, with a penultimate cysteine residue which is linked to J chain in polymeric forms [35] . In monomeric forms, this penultimate cysteine can apparently form a disulphide bond with the homologous cysteine on the other a chain, another cysteine in the other a chain or occasionally with other, non-immunoglobulin proteins, such as albumin or acantitrypsin. In dimeric forms the individual monomers are linked by disulphide bonds utilizing this penultimate cysteine residue. The other cysteine which makes up this pair is the subject of some debate, but it is probably Cys-3 11 on the CH2 domain [36] .
It is possible that studies on myelomas which show greater tendency to polymerize might not reflect the normal situation.
Human IgAl and IgA2 heavy chains differ in only 22 amino acids, predominantly due to a deletion in IgA2 of 13 amino acids in the hinge region (Fig. 1) . The hinge region of IgAl is composed of an unusual repeating sequence rich in proline, serine and threonine, the serines carrying 0-linked sugars. The lack of this region in IgA2 makes it resistant to the action of a number of bacterial proteinases which cleave IgAl in the hinge region and
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Residue are thought to be important in the pathogenicity of the bacteria. The allotypic variants of IgA2, IgA2m(l) and IgA2m(2), differ in important respects [37] . A2m(l) molecules lack the disulphide bond between the heavy and light chains, allowing the two light chains to be linked to each other. Under denaturing conditions, the molecule therefore splits into heavy chain and light chain dimers. The A2m(2) allotype has the usual interchain disulphide bond. The A2m(l) a chain is a hybrid between Al and A2m (2) in that the CH3 domain is identical to that in acl whereas the CH1 and CH2 are identical to a2m (2) . Both forms of IgA2 lack the hinge region (Fig. 2) . The amino acid sequences of human and murine J chain have been determined [38] . It has eight cysteine residues, six in intrachain disulphide bonds. In polymeric IgA, two J chain cysteines are usually disulphide-linked to the penultimate cysteines of a chains. In some IgA molecules, a second disulphide bond to a cysteine residue in the CH2 domain has been demonstrated. The exact nature of the interaction between the a chain and J chain has not been elucidated. Although it has been shown that most molecules of secretory dimeric IgA contain one molecule of J chain [39] , it is not clear whether all serum dimeric IgA contains J chain. Some studies [40] have shown polymeric IgA myelomas with an average of two J chains per dimer, but others which lack J chain have also been reported [41] .
SC is produced by epithelial cells lining the mucosal surface, unlike the IgA and J chain which are synthesized in mucosal lymphocytes. SC is found in secretions complexed to IgA (or IgM) and also as a free glycoprotein. It has been shown to stabilize markedly the structure of secretory IgA and to increase its resistance to proteolysis [42] . SC is somewhat heterogeneous, with molecular masses reported from 50 to 90 kDa. It is heavily glycosylated with N-linked sugars. The amino acid sequence of SC from rabbit and human has been determined [43, 44] . Human SC contains 20 cysteine residues. Although it confers marked stability to secretory IgA, in its free form, it is remarkably susceptible to proteolysis. [32] . Immunochemical studies [45] have suggested that both the CH2 and CH3 domains of the IgA are equally and independently involved in the interaction with SC (Fig. 4) [48] . The 0-linked sugars isolated from milk sIgA appear to be more complex and heterogeneous, containing sialic acid, fucose and N-acetylglucosamine [49, 50] .
The N-linked sugars of serum and secretory IgA are complex and variable in structure [51] . Both J chain and SC are also glycosylated, J chain (8 % carbohydrate) with a single N-linked chain, SC (22 % carbohydrate) with five to seven chains, making sIgA a relatively heavily glycosylated molecule. It is generally accepted that SC confers marked stability on the sIgA and this might be due to the carbohydrate. It has been proposed that mannose-specific bacterial adhesins might interact with IgA2, both serum and secretory, through these N-linked sugars [52] .
The interaction of the asialoglycoprotein receptor with the carbohydrate chains of IgA will be discussed later.
The purification of IgA and separation of IgA I and IgA2 have been greatly facilitated by the availability of a lectin, jacalin, purified from the seed of the jackfruit (Atrocarpus spp.), which has specificity for galactose residues such as those on the hinge region of IgAl [53] . Jacalin binds to serum or sIgAl but does not recognize IgG,IgM or IgA2 of either allotype [54, 55] . The lectin has been used extensively for the affinity purification of IgAl, although care must be taken since there does appear to be heterogeneity in the jacalin preparations from different sources, some binding only to serum and sIgAl whilst others show weaker but significant binding to IgA2 [56] [57] [58] . Jacalin does not bind to mouse, rat, pig, goat, horse, cow or dog IgA [59, 60] . Although the lectin is of considerable value in the purification of human IgAl it is not totally specific, recognizing other serum and also cell-surface proteins. The interaction with IgA is unaffected by bivalent metal ions or by many detergents, although it is inhibited by denaturing agents. Jacalin has an apparent molecular mass of 40-50 kDa and is a tetramer comprised of two distinct types of polypeptide chain [61, 62] . Since serum and sIgAl bind with similar affinity it appears that the hinge region of IgAl is readily accessible in both species. [63] .
Unbound receptor appears to be cleaved to release free SC found in secretions. The transcytosis in specific vesicles has been studied extensively and reviewed recently [5, 64] .
Study of rabbit SC, which is highly heterogeneous in terms of molecular mass and glycosylation, has suggested that the first N-terminal domain of SC is necessary and sufficient for efficient non-covalent binding to dimericIgA [65] . Immunochemical studies using a large panel of monoclonal antibodies against human SC showed that most SC-related epitopes on sIgA appear to be generated by the physical interaction of SC with dimeric IgA, whereas most epitopes on free SC are masked or altered by this interaction [66] . These results are consistent with the marked decrease in sensitivity of the SC to proteases which occurs on binding to IgA, suggesting marked changes in the conformation of the receptor after binding.
In rodents the poly(Ig) receptor is expressed on the sinusoidal surface of hepatocytes and the liver plays a key role in the translocation of IgA into the upper gastrointestinal tract [5, 64] . Polymeric forms of IgA are efficiently transported from the circulation into the bile, possibly transporting IgA-bound antigens at the same time. In man and in some other animals this mechanism does not appear to function [67, 68] , although it has recently been shown that human hepatocytes do express some poly(Ig) receptor [69] . It is well established that the liver does play an important role in the IgA system even in man. Liver disease is frequently associated with marked elevations in the serum IgA levels and in increased serum polymeric IgA [70] .
Although human biliary epithelial cells do express the receptor which can effect limited secretion of pIgA into bile, most of the biliary pIgA is synthesized locally in biliary tract plasma cells [71] .
IgA interactions with hepatocytes can also be mediated by the asialoglycoprotein receptor or hepatic binding protein [72] [77, 78] . Since aiantiproteinase is a potent inhibitor of leucocyte elastase and thus an important regulator of inflammation, it is interesting that the IgA-inhibitor complex has also been detected in the sera of patients with rheumatoid arthritis [79] .
HC-protein is a heterogeneously charged low-molecular-mass protein of unknown function first isolated from human urine. It is found in serum at aroung 40 mg/l, half of which is complexed with IgA [80] . The low-molecular-mass form in serum appears to be identical in amino acid sequence to the urinary protein, although its charge heterogeneity is less pronounced. The HC protein is not found in IgA-deficient plasma nor is it found associated with other proteins in normal or myeloma sera. It appears to be associated almost exclusively with monomeric IgA, even in plasma containing predominantly dimeric IgA myelomas [81, 82] . On SDS gels the plasma high-molecular-mass protein HC appears to be made up of four polypeptide chains: two light immunoglobulin chains, one IgA a chain, and one chain with of approx. 90 kDa having both a-chain and protein HC antigenic determinants, although some reports suggest the 90 kDa component to lack IgA epitopes.
Both HC-protein and its IgA complex are inhibitors of the directed (chemotactic) but not the random migration of neutrophils [83] . Concentrations of HC-protein and its IgA complex producing significant inhibition of the chemotaxis are found to occur in plasma from healthy and diseased individuals as well as in synovial fluid from patients with rheumatoid arthritis, suggesting that HC-protein and its IgA complex play physiological roles in the regulation of the inflammatory response. In addition to these serum proteins shown to bind to the free SH group of monomeric IgA, a recent report [84] suggests an association between fibronectin and IgA in patients with primary IgA nephropathy. Complexes are able to bind collagens I, II, and IV through the collagen-binding site of the fibronectin. In colostrum and milk, the bacteriostatic effect of sIgA in vitro has been shown to be increased in the presence of the iron-binding proteins lactoferrin and transferrin [85, 86] , some of the lactoferrin being covalently bound to sIgA [87] . BACTERIAL IgA RECEPTORS AND PROTEIN A Since IgA is the major immunoglobulin at mucosal surfaces, it is not unexpected that pathogenic bacteria have evolved mechanisms by which to evade the effects of these antibodies. One mechanism utilized by some streptococci involves a cellsurface receptor which recognizes the Fc region of IgA. This receptor, found on group A strains of certain M types, plays an important role as a virulence factor for these micro-organisms because of its anti-phagocytic activity [88, 89] [100, 101] . Cloning of the gene from serotype b shows that the enzyme also has strong homology with the proteinase from N. gonorrhoeae, both having precursors which undergo similar processing on secretion [102] . The gene for the IgA proteinase from the oral bacterium, Streptococcus sanguis, has also been cloned [103] . It does not hybridize with chromosomal DNA of gram-negative bacteria that excrete IgA proteinase or S. pneumoniae, although the IgA proteinases of these two streptococcal species cleave the identical peptide bond in the human IgAl heavy-chain hinge region.
In addition to these classical IgA proteinases, a number of other species have been shown to secrete proteinases which cleave IgA. Some of these enzymes have the characteristic limited specificity, whilst others have broader specificity. A survey of gram-negative bacteria isolated from patients with urinary tract infections showed many (seven genera, eight species) to hydrolyse myeloma IgA but not IgG, IgM or secretory IgA [104] . Some of the proteinases responsible for this hydrolysis were dissimilar in the specificity of their IgA cleavage sites. We have shown that many species of Proteus, a common pathogen of the urinary tract, produce an EDTA-sensitive proteinase which cleaves secretory and serum IgAl and IgA2 outside the hinge region [105] . The purified 50 kDa enzyme has rather broad substrate specificity, cleaving not only the two isotypes of IgA but also IgG and a limited number of non-immunoglobulin proteins such as secretory component, casein and bovine serum albumin [46] .
Only one other IgA proteinase has been shown to cleave both IgAl and IgA2 selectively. This is secreted by a strain of Clostridium ramosum associated with ulcerative colitis [106] . This enzyme cleaves a Pro-Val bond found just before the hinge region in the a chains of IgAI and the IgA2m(l) allotype, but not in IgA2m(2) where it is Arg-Val. The proteinase, like most IgA proteinases, is sensitive to EDTA [107] . Other [112] . Several reports have shown that IgA antibodies will inhibit the activation of the classical pathway by IgG or IgM antibodies recognizing the same antigen [13, 113] . This has been interpreted to suggest that serum IgA might limit the activation of complement by bacteria entering the circulation from mucosal sites and therefore direct the micro-organisms into macrophages and away from polymorphonuclear leukocytes, allowing removal and processing of antigen whilst limiting the inflammatory response [114] . A recent report [115] from the same laboratory, which shows that specific human IgAl antibodies are able to kill N. meningitidis through activation of the classical pathway, suggests that further work is needed in this area.
There is evidence from several laboratories that the alternative pathway of a number of species is activated by aggregated IgA.
This observation, first reported in 1971 [116] [126] . Although some reports suggest these complexes to be small, other studies [127] [131] . A large number of studies have shown aggregated IgA to stimulate or inhibit a variety of neutrophil functions. The neutrophil receptor was first demonstrated by Fanger and colleagues by using rosetting techniques [132, 133] . They also showed that the expression of the receptor on blood neutrophils was apparently enhanced by overnight incubation with IgA. Oral neutrophils expressed more receptors per cell than neutrophils in blood and were capable of phagocytosing target cells coated with IgA alone. In functional studies, IgA-R appeared to co-operate with receptors for IgG in enhancing the phagocytosis of target cells coated with IgG and IgA.
Other studies have also shown that the expression of these receptors can be controlled by external factors. GM-CSF and G-CSF, but not IL-3, have been shown to induce a change from low-to high-affinity neutrophil IgA-R receptors within 30 min, a change which is associated with the development of IgA-mediated phagocytosis [134] . The human promyelocytic leukaemia cell line HL-60, which does not express IgA-R, can be induced to do so by treatment of with the differentiating agent calcitriol. Again, these cells are capable of ingesting IgA-coated erythrocyte targets [135] .
Several early studies, using mainly animal serum IgA, human myeloma IgA or human colostral secretory IgA, showed that IgA did not opsonise erythrocytes [136, 137] , cells or micro-organisms [138] [139] [140] for phagocytosis by human neutrophils. Other studies [14] suggested that normal serum and sIgA could inhibit the binding and phagocytosis of yeast. This inhibition, which was enhanced by heat aggregation of the IgA, was apparently due to the binding of the IgA to the neutrophil. Aggregated IgA has also Vol. 271 been shown to inhibit other neutrophil functions. An inhibitor of neutrophil chemotaxis found in the serum of patients with liver disease or IgA nephropathy has been identified as polymeric IgA [15, 141, 142] .
Human IgA myeloma proteins have been shown to inhibit the chemotaxis and chemotactic peptide-induced chemiluminescence of neutrophils [143] . This inhibition is mediated by the Fc part of the molecule and potentiated by heating and aggregation. The binding and phagocytosis of aggregated IgA has been demonstrated in several laboratories [144, 145] , both in vitro where the rate of uptake of aggregated IgA myeloma proteins and subsequent release of granule enzymes is similar to that of IgG aggregates, and in vivo where IgA immune complexes have been detected in neutrophils isolated from patients with IgA nephropathy [146, 147] .
We have studied the interaction of serum IgA with neutrophils using several different systems. Whilst investigating the ability of pathological sera to opsonise yeast we identified a heat-stable opsonic activity in the sera of patients with liver and inflammatory bowel disease which was due to IgA anti-(yeast mannan) antibody [17] . Using an assay for yeast phagocytosis in which both yeast and neutrophils are kept in suspension, IgA showed greater opsonic activity than IgG anti-mannan antibody. If yeast and neutrophils were allowed to settle, IgA and IgG were equally efficient opsonins. IgA antibodies are at least as efficient as IgG in causing the degranulation of neutrophils as measured by enzyme release or by triggering of the respiratory burst. Similar effects have also been observed for IgA-opsonized S. aureus [18] .
Neutrophils will bind to IgA-Sepharose or IgG-Sepharose, but not to B3SA-Sepharose, and this binding elicits a similar respiratory burst and degranulation response. We have used IgA-Sepharose to purify the IgA-R from human neutrophils by affinity chromatography of detergent-solubilized membrane extracts [148] . The receptor, identified initially from radiolabelled cell membrane proteins, but more recently by silver staining of the purified protein, appeared on SDS gels as a diffuse band corresponding to a protein of Mr 50-70 kDa. Using IgGSepharose under identical conditions, IgG FcyRII could be isolated. When judged by the amount of radioactivity or protein recovered, the amount of IgA-R purified was similar to that of the FcRyII receptor. The amount of IgA-R recovered was less than the amount of FcRyIII which could be precipitated from the same neutrophil extract using CD16 monoclonal antibodies. Since in our experiments the low affinity of the FcRyIII receptor prevented purification on the IgG-Sepharose resin, it appeared that the affinity of IgA-R for IgA must be similar to that of FcRyII for IgG.
After elution from the IgA-Sepharose affinity columns with 0.5 M-acetic acid, upon neutralization IgA-R rebound specifically to IgA-but not to IgG-or BSA-Sepharose. The binding of receptor to IgA-Sepharose was blocked by IgAl or IgA2 in both monomeric and secretory forms but not by IgG or IgM. This confirmed, directly, earlier reports on the specificity of the receptor showing IgAl and IgA2 to be equally efficient in their capacity to inhibit rosette formation [145, 149, 150] . Our results suggest the affinity of the receptor for IgA is 5 x 107 M-1 [151] . We have also shown recently [15la] that when coated onto microtitre plates, serum or sIgA of either subclass or IgG are able to elicit similar levels of lucigenin-enhanced chemiluminescence from neutrophils. Although the binding site on IgA has not been fully determined, several studies have suggested a site on the Fc region. Since a IgA half-molecule lacking the CH3 domain is also recognized, it appears that it is the CH2 domain which is involved in binding to the receptor [149] .
Taken together, these results demonstrate the presence on phagocytic cells of specific IgA-R with at least equal affinity and [143, 152, 153] . Peripheral blood monocytes and alveolar macrophages have been demonstrated to ingest IgA-coated particles and bacteria [154] . Recently, Monteiro et al. [155] have isolated an IgA-R from human monocytes and related cell lines which was similar to that found on neutrophils. Receptors recognizing human IgA have also been detected in heterologous systems using macrophages and macrophage-related cells from mouse, rat and rabbit. In mouse, a subpopulation of alveolar macrophages (around 20 %) express the receptor although this value increases along with an increase in ligand density on stimulation in vitro or in vivo [156] coincident with an increase in phagocytic activity.
The significance of IgA-R on these cells remains unclear. Ward and colleagues in a series of papers [157] [158] [159] have studied the interaction of lung macrophages and neutrophils with IgA and IgG immune complexes. They have shown that when IgA is instilled into the airways of rats and antigen injected intravenously, acute lung injury occurs, which is dependent on antigen and directly proportional to the amount of IgA. Lung injury related to IgA-containing immune complexes is complement-dependent but neutrophil-independent, whereas similar lung pathology due to IgG complexes is complement-and neutrophil-dependent. In vitro, rat lung interstitial and alveolar macrophages incubated with IgA or IgG immune complexes produce similar amounts of superoxide in a dose-dependent manner. In contrast, peripheral blood neutrophils respond to IgG immune complexes but not to IgA immune complexes; monocytes respond to neither. The results suggest that in the rat, IgG immune complex lung injury is primarily neutrophilmediated, wheras IgA complex lung injury is predominantly macrophage-mediated.
It has been widely suggested that macrophages might also be involved in the clearance of IgA-containing immune complexes. Evidence in humans is limited but studies have been made in mice [160] . The rapid phase of removal of large IgA aggregates involves the clearance by the liver with an insignificant amount ending up in the bile. Heavy polymers of dIgA or mIgA predominantly localize in Kupffer cells [161, 162] , a subpopulation of which express IgA-R [163] . Although these results point to a role for the reticuloendothelial system in generation of inflammation and the removal of IgA immune complexes, the mechanism remains unclear. Other studies [164] on the in vitro binding, internalization and degradation of IgA immune complexes (IC) by resident rat peritoneal macrophages suggest that the asialoglycoprotein receptor is involved. Although there is little information concerning the role of IgA-R on mononuclear phagocytes in the killing of micro-organisms, a recent study demonstrated the phagocytosis of erythrocytes and release of superoxide triggered by IgA [165] . Human monocytes have been described to have ADCC activity [166, 167] . Of particular significance is the observation that a human monoclonal anti-pneumococcal IgA produced from an EBVtransformed cell line induces direct killing and increases the phagocytosis of these bacteria by mouse macrophages in vitro although the antibody does not fix complement [168] .
IgA RECEPTORS ON LYMPHOCYTES AND THE CONTROL OF THE IgA RESPONSE IgA-R have been detected on subpopulations of T cells, B cells and also non-T non-B cells of several species both in the circulation and in lymphoid tissues, especially the gut-associated lymphoid tissue [153, [169] [170] [171] . The percentage of lymphocytes expressing IgA-R is usually low but can be increased upon activation either by culturing overnight with IgA or by mitogenic stimulation in the absence of IgA. Several reports have suggested an increase in the number of lymphocytes bearing IgA-R in diseases associated with raised serum IgA or IgA immune complexes, such as IgA nephropathy [172] or Crohns disease [173] . IgA-R can also be induced by aggregated IgA purified from the sera of patients with IgA nephropathy [174] .
Human T cells increase their expression of IgA-R on stimulation with concanavalin A or phytohaemagglutinin [169, 175] . Human B cells activated with S. aureus, anti-IgM antibodies or E. coli LPS also show increased numbers of IgA-R positive cells [175, 177] [180] . Most of the detailed functional studies on lymphocyte IgA-R have been carried out in mice [181, 182] . In one extensively studied murine system, Kiyono and colleagues [183] [184] [185] [187] . IgA-R+ human T cells pre-incubated with aggregated IgA have been shown to selectively suppress the ability of pokeweed mitogen-stimulated B cells to produce IgA [188] .
The nature of the IgA receptor and IgA-BF has been studied extensively by Yodoi and colleagues [189] [190] [191] [192] [193] [194] [195] . Although the IgA receptor and binding factor have not yet been fully characterized, a recent, as yet unconfirmed, report has suggested that the murine lymphocyte IgA-R might be serologically related to secretory component [196] .
CONCLUDING REMARKS
It is clear that IgA is able to bind to a variety of soluble and cell bound proteins. In many cases the full significance of these interactions has still to be elucidated. There is ample evidence that immunity to infection at mucosal surfaces is mediated by IgA. There is increasing evidence that serum IgA might also play a role in immunity although this has yet to be determined. Selective deficiency of IgA is one of the most frequent immunodeficiencies although these deficiencies are seldom complete [197] . This deficiency can be associated with a number of autoimmune diseases, recurrent infections and atopy, but not all deficients are symptomatic [19] 
